(Q41811716)

12 October 2017

Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate (English)

1 reference

12 October 2017

1 reference

1 reference

3

Danhof M

1 reference

12 October 2017

Della Paschoa OE

1

1 reference

12 October 2017

Voskuyl RA

series ordinal

2

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

British Journal of Pharmacology

12 October 2017

1 reference

12 October 2017

125

1 reference

12 October 2017

7

1 reference

12 October 2017

1610-1616

1 reference

Interactions of valproic acid with phenytoin

12 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

Valproic acid and plasma levels of phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

Pharmacokinetic-pharmacodynamic (PK-PD) modelling in non-steady-state studies and arterio-venous drug concentration differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

Brain Uptake of Phenytoin, Phenobarbital, and Diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

Problems in therapeutic drug monitoring: free drug level monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Drug interactions in epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Pharmacodynamic interactions between phenytoin and valproate: individual and combined antiepileptic and neurotoxic actions in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Gas chromatographic method for the measurement of sodium valproate utilization by kidney tubules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Plasma protein binding kinetics of valproic acid over a broad dosage range: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Concepts and usefulness of pharmacokinetic-pharmacodynamic modelling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Drug interactions with valproic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: phenytoin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

New visions in the pharmacology of anticonvulsion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Estimation of amobarbital plasma-effect site equilibration kinetics. Relevance of polyexponential conductance functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Pharmacokinetic drug interactions with phenytoin (Part I).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

How valproate and phenytoin affect the ionic conductances and active transport characteristics of the crayfish giant axon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Antiepileptic drugs. A review of clinically significant drug interactions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Clinically relevant anti-epileptic drug interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Sodium channels as molecular targets for antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Pharmacokinetic interactions of the new antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Relationship between concentration and anticonvulsant effect of phenytoin against electroshock-induced seizures in rats: comparison of sampling sites for concentration determinations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

A method for prediction of phenytoin levels in the acute clinical setting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Protein binding and whole blood assays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Brain interstitial fluid and intracellular distribution of phenytoin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Pharmacokinetics of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Biophase equilibration times

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Determination of the threshold for convulsions by direct cortical stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Properties of the convulsive threshold determined by direct cortical stimulation in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702235

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0702235

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

9884091

1 reference